The panel addresses questions such as:
- How can you tell if a treatment is legitimate or not?
- What rights should terminally ill and desperate patients have to try experimental treatments?
- Who gets to decide and what is the path forward?
- What steps should established institutions take to address stem cell tourism?
Predatory stem cell clinics around the world are offering unapproved treatments at high prices, often leaving their patients with little relief or disastrous consequences. In this panel discussion, members of the John Hopkins Berman Institute of Bioethics, patient advocates, and scientists discussed what must be done to crack down on “stem cell tourism”, how we can address the ethical issues surrounding it, and the necessary steps for bringing legitimate treatments to patients.